BridgeBio Pharma Inc (BBIO)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$74.46

Buy

$75.64

arrow-up$1.085 (+1.46%)

Prices updated at 13 Dec 2025, 00:39 EST

Prices minimum 15 mins delay

Prices in USD

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

-

CEO

Dr. Neil Kumar, PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

730

Head office

3160 Porter Drive

Palo Alto

United States

94304

+1 650 391-9740

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Thomas Trimarchi, PhD Principal Financial Officer and President	0.64m
Dr. Charles J. Homcy,M.D. Lead director	0.05m
Mr. Fred Hassan Lead Independent Director	0.05m
Mr. James C. Momtazee Independent Director	0.05m
Dr. Randal W. Scott,PhD Independent Director	0.05m
Dr. Frank P. McCormick, D.Sc.,F.R.S.,PhD Director	0.05m
Dr. Eric Aguiar, M.D. Independent Director	0.05m
Mr. Ali J. Satvat Independent Director	0.05m
Mr. Douglas A. Dachille Independent Director	0.05m
Dr. Neil Kumar, PhD Director; Chief Executive Officer of the Company and Eidos Therapeutics, Inc.	0.99m
Ms. Jennifer E. Cook Independent Director	0.05m
Mr. Ronald J. Daniels Independent Director	0.05m
Dr. Andrew W. Lo, PhD Independent Director	0.05m
Dr. Hannah A. Valantine, M.D. Independent Director	0.05m
Ms. Andrea John Ellis Independent Director	0.05m
Ms. Maricel M. Apuli Chief Accounting Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
KKR Genetic Disorder LP	25,260,971
Vanguard Group Inc	16,484,985
Viking Global Investors LP	15,977,849
BlackRock Inc	14,411,203
Kohlberg Kravis Roberts & Co LP	13,260,971

Director dealings

Date chevron-l-regular chevron-r-regular	Action
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
30 Dec 2024	-
26 Dec 2024	-
24 Dec 2024	-
24 Dec 2024	-
10 Dec 2024	-
10 Dec 2024	-
10 Dec 2024	-
19 Nov 2024	-
19 Nov 2024	-
19 Nov 2024	-
16 Nov 2024	-
16 Nov 2024	-
16 Nov 2024	-
16 Nov 2024	-
16 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.